FibroGen, Inc.
FGEN
$6.89
-$0.03-0.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.64M | 17.98M | -17.08M | -15.54M | -32.93M |
| Total Depreciation and Amortization | 327.00K | 352.00K | 739.00K | 781.00K | 820.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.41M | -1.02M | 13.06M | 5.43M | 6.88M |
| Change in Net Operating Assets | -5.65M | -47.78M | -5.09M | -30.53M | -34.05M |
| Cash from Operations | 2.72M | -30.47M | -8.38M | -39.87M | -59.29M |
| Capital Expenditure | -16.00K | -141.00K | -82.00K | -14.00K | -29.00K |
| Sale of Property, Plant, and Equipment | -- | 206.00K | 837.00K | 3.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 1.66M | 0.00 | 72.25M | 51.31M |
| Cash from Investing | -16.00K | 1.72M | 755.00K | 72.24M | 51.28M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.00K | -4.00K | -16.00K | -8.00K | -12.00K |
| Issuance of Common Stock | -- | 23.00K | 0.00 | 116.00K | -- |
| Repurchase of Common Stock | -37.00K | -14.00K | -111.00K | -76.00K | -153.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -46.00K | -- | -- | -- | -- |
| Cash from Financing | -88.00K | 5.00K | -127.00K | 32.00K | -165.00K |
| Foreign Exchange rate Adjustments | 1.41M | -87.00K | -1.96M | 2.58M | 223.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.02M | -28.83M | -9.71M | 34.98M | -7.95M |